On the contrary, when assessing the ERG–PTEN association, we observed that PTEN homogeneous loss was linked to ERG positivity which was mostly found in low-grade prostate carcinomas, and PTEN heterogeneous loss was linked to a negative ERG expression which constitutes a key finding in high-grade carcinomas. Here, PTEN is linked to prostate carcinoma.